Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences

Core Insights - Lifecore Biomedical, Inc. will participate in multiple investor conferences and industry events in March 2025, showcasing its commitment to engaging with investors and industry stakeholders [1][2]. Group 1: Upcoming Events - Lifecore will present at the TD Cowen 45th Annual Health Care Conference on March 4, 2025, where CEO Paul Josephs will deliver a corporate presentation [1]. - The company will also participate in the KeyBanc Capital Markets Healthcare Forum on March 19, 2025, featuring a fireside chat with CEO Paul Josephs [2]. - Additionally, Lifecore will attend DCAT Week 2025 from March 17-20, 2025, engaging in meetings with current and prospective customers [2]. Group 2: Company Overview - Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) specializing in the development, fill, and finish of sterile injectable pharmaceutical products [3]. - The company has over 40 years of expertise in manufacturing premium, injectable-grade hyaluronic acid, serving global and emerging biopharmaceutical and biotechnology companies [3].